Why the study?
Prior S-ICD cohorts had less heart disease and fewer comorbidities than standard ICD populations, leaving acute performance uncharacterized in primary prevention patients with LVEF ≤35%.
Does subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation have high acute success and low perioperative complication rates in primary prevention patients with LVEF ≤35%?
Does subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation have high acute success and low perioperative complication rates in primary prevention patients with LVEF ≤35%?
S-ICD implantation demonstrates high procedural success and low perioperative complication rates in a higher-risk primary prevention cohort with LVEF ≤35%, though higher BMI warrants careful implant technique.
Answers are grounded in this paper and cite their sources.
S-ICD acute performance in higher-comorbidity primary-prevention LVEF ≤35% patients needs confirmation; this cohort study leaves open generalizability to broader populations.
BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (S-ICD) has shown favorable outcomes in large registries with broad inclusion criteria. The cohorts reported had less heart disease and fewer comorbidities than standard ICD populations. OBJECTIVE: The purpose of this study is to characterize acute performance for primary prevention patients with a left ventricular ejection fraction (LVEF) ≤35% (primary prevention ≤35%). METHODS: Primary prevention ≤35% patients with no prior documented sustained ventricular tachycardia (VT), pacing indication, end-stage heart failure, or advanced renal failure were prospectively enrolled. Analyses included descriptive statistics, Kaplan-Meier time to event, and multivariable linear and logistic regression. RESULTS: In 1112 of 1116 patients, an S-ICD was successfully implanted (99.6%). Predictors for longer procedure time included 3-incision technique, higher body mass index (BMI), performing defibrillation testing (DFT), imaging, younger age, black race, and European vs North American centers. Patients undergoing DFT (82%) were successfully converted (99.2%; 93.5% converting at ≤65 J). Higher BMI was predictive of failing DFT at ≤65 J. The rate of 30-day freedom from complications was 95.8%. Most complications involved postoperative healing (45%) or interventions after DFT or impedance check (19%). CONCLUSION: The procedural outcome data of UNTOUCHED reinforce that S-ICD therapy has low perioperative complication rates and high conversion efficacy of induced ventricular fibrillation, even in a higher-risk cohort with low LVEF and more comorbidities than previous S-ICD studies. Higher BMI warrants more careful attention to implant technique.
No takes yet. Share an insight, caveat, or question.
Boersma et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: